IBSA, a pharma company actively involved in reproductive health, has acquired Aura Fertility, an app with the goal of improving the IVF experience. This move is in line with IBSA’s goal to improve patient experiences and outcomes in fertility by focusing on the emotional aspects and challenges associated with IVF.
London-based Aura Fertility was established in 2020 by Abi Hannah, Karen Hanson, and Jo Living, driven by their personal encounters with miscarriages and IVF challenges. The company’s B2C app saw rapid adoption, with 6,000 downloads within six months post-launch, which helped the team raise $700K in pre-seed funding shortly thereafter.
The Aura Fertility app, focused on evidence-based psychosocial care, uses AI to refine patient experiences and overall wellness, aiming to improve pregnancy outcomes. It is meant to serve as a vital companion throughout the IVF process, delivering expert-driven wellbeing support in conjunction with clinical care.
IBSA, a multi-national pharma company known for its range of infertility treatments, including progesterone solutions and extractive gonadotropins with unique glycosylation due to specific purification processes, views the acquisition as a strategic extension of its commitment to the fertility domain. By integrating Aura Fertility’s application, IBSA now aims to enhance its offerings, providing a more comprehensive support system for IVF patients that includes emotional support, information access, and expert advice.
According to the Aura Fertility website, the app will relaunch in the near future.
